New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 31, 2012
07:38 EDTQCORQuestcor a target for insurers, short-sellers, NY Times says
Questcor (QCOR) expanded the marketing for its Acthar gel and raised the price dramatically, bringing it a growth rate and profit margin that drove a strong advance in its stock, but now the company is under fire from some doctors, insurance companies and critical short-sellers, reported The New York Times. Reference Link
News For QCOR From The Last 14 Days
Check below for free stories on QCOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
13:13 EDTQCOREinhorn bought Lam Research shares, sold Rite Aid last quarter
Subscribe for More Information
12:18 EDTQCORGreenlight discloses short positions in Safeway, Questcor, Bloomberg says
Subscribe for More Information
10:02 EDTQCOROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:22 EDTQCORQuestcor downgraded to Perform from Outperform at Oppenheimer
July 24, 2014
09:10 EDTQCORQuestcor expects insurance coverage for Acthar to remain favorable, consistent
Subscribe for More Information
09:10 EDTQCORQuestcor reports Q2 H.P. Acthar gel sales up 39% to $188.5M
Subscribe for More Information
09:10 EDTQCORQuestcor reports Q2 adjusted EPS $1.85, consensus $1.74
Subscribe for More Information
July 21, 2014
07:36 EDTQCORMallinckrodt price target raised to $95 from $85 at Jefferies
Subscribe for More Information
July 17, 2014
11:12 EDTQCOROptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use